about
Overexpression of miR-128 specifically inhibits the truncated isoform of NTRK3 and upregulates BCL2 in SH-SY5Y neuroblastoma cellsDyrk1A haploinsufficiency affects viability and causes developmental delay and abnormal brain morphology in miceEvidence for the biogenesis of more than 1,000 novel human microRNAs.SeqBuster, a bioinformatic tool for the processing and analysis of small RNAs datasets, reveals ubiquitous miRNA modifications in human embryonic cells.A pathogenic mechanism in Huntington's disease involves small CAG-repeated RNAs with neurotoxic activity.Small non-coding RNAs add complexity to the RNA pathogenic mechanisms in trinucleotide repeat expansion diseases.Targeting CAG repeat RNAs reduces Huntington's disease phenotype independently of huntingtin levels.RNA toxicity induced by expanded CAG repeats in Huntington's disease.Specific small-RNA signatures in the amygdala at premotor and motor stages of Parkinson's disease revealed by deep sequencing analysis.Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome.A non-biased framework for the annotation and classification of the non-miRNA small RNA transcriptome.RCAN1 (DSCR1) increases neuronal susceptibility to oxidative stress: a potential pathogenic process in neurodegeneration.MicroRNA expression profiling in blood from fragile X-associated tremor/ataxia syndrome patients.Increased NR2A expression and prolonged decay of NMDA-induced calcium transient in cerebellum of TgDyrk1A mice, a mouse model of Down syndrome.Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models.Motor phenotypic alterations in TgDyrk1a transgenic mice implicate DYRK1A in Down syndrome motor dysfunction.Selective early induction of synaptosomal-associated protein (molecular weight 25,000) following systemic administration of kainate at convulsant doses in the rat.Regional and subtype-dependent miRNA signatures in sporadic Creutzfeldt-Jakob disease are accompanied by alterations in miRNA silencing machinery and biogenesis.The discovery potential of RNA processing profiles.Bcl-2, Bax, and Bcl-x expression in the CA1 area of the hippocampus following transient forebrain ischemia in the adult gerbil.MicroRNA Expression in the Locus Coeruleus, Entorhinal Cortex, and Hippocampus at Early and Middle Stages of Braak Neurofibrillary Tangle Pathology.Expression of synaptic proteins in the developing rat cerebellum following ionizing radiation.Expression of proteins linked to exocytosis and neurotransmission in patients with Creutzfeldt-Jakob disease.Transient increase of synapsin-I immunoreactivity in the mossy fiber layer of the hippocampus after transient forebrain ischemia in the mongolian gerbil.Brain-derived neurotrophic factor does not prevent ionizing radiation-induced apoptosis in the developing rat brain.Transgenic mice overexpressing the full-length neurotrophin receptor TrkC exhibit increased catecholaminergic neuron density in specific brain areas and increased anxiety-like behavior and panic reaction.Dystrophic neurites of senile plaques are defective in proteins involved in exocytosis and neurotransmission.Distribution of fibroblast growth factor receptor-1 (FGFR-1) and FGFR-3 in the hippocampus of patients with Alzheimer's disease.Blood expression profiles of fragile X premutation carriers identify candidate genes involved in neurodegenerative and infertility phenotypes.Prion protein deposition and abnormal synaptic protein expression in the cerebellum in Creutzfeldt-Jakob disease.Differential expression of members of the RCAN family of calcineurin regulators suggests selective functions for these proteins in the brainExpression of Caspases and Their Substrates in the Rat Model of Focal Cerebral Ischemia8-Azido-Nucleotides as Substrates of Torpedo Electric Organ Apyrase. Effect of Photoactivation on Apyrase ActivityInhibition of ATP-diphosphohydrolase (apyrase) of Torpedo electric organ by 5′-p-fluorosulfonylbenzoyladenosine
P50
Q21263029-D448CB7C-9F10-4AC1-A7C9-052D1DA3C8D8Q30531707-EA3FAE37-DE78-4C8E-843A-A4847DDE3C75Q33744951-CC967D07-7325-43F7-AB98-EF36FB66C239Q34087933-1933D2DA-BBC1-4929-A575-9CE469A9F9A2Q34181368-7B027B33-DB33-488A-918C-99E941B0123FQ38172118-1C4B55F0-833E-4273-AB89-C6207E886F78Q38290349-0B3EFE5A-28EF-4C20-A356-4B483D84BE57Q38928719-ED8C90F9-0BFA-418D-BC39-3C5D57CF93E9Q40360134-6237767A-F51E-4523-AF5F-73BA3C52DF10Q43736456-04CF51CB-5F9F-4389-A2C9-9B3E78954432Q44501479-60709D2F-F47E-4231-AD35-B4DCAFF0482AQ44733824-C015598E-0CDC-4118-9CF6-39F9CCEB805DQ45293759-A8F9064B-6762-46B8-BDF2-B8E641352E20Q46387287-D007A621-5C6D-41CE-AF97-EF902BB5710DQ46768378-DAFFDF0D-022B-4CD0-8119-A908EBB56377Q47232491-017C1F6B-B465-4A57-B68A-E760EA9210DCQ47264762-096FCDCA-9FDC-4316-BF11-024E20BE9E7AQ47550368-E39A6490-DC22-484F-865B-E856A7F275E2Q47603928-AC651048-3BED-4621-9193-C8D40C91CEDDQ47718875-67A6E1C4-9321-4F80-B65A-2848C4F581C4Q47778002-79E7D74E-5DB3-4C1F-BA9D-F9C02087FDAEQ48117641-7DF2D7C6-D8AC-4779-8ECF-06917662A399Q48200986-09ADDAC9-2628-4549-89C2-873D5494E672Q48241979-05FFA899-617F-442F-B83C-6A7166938168Q48321266-222BD342-BED4-434A-AE45-F898C824874AQ48424400-9D0CBBBE-B40F-48C6-8EB8-4AF5F164BAAFQ48463732-D191F5BE-41BE-4593-835E-C008AC1C0791Q48510425-3FFBAD63-8E13-444E-92C4-CA1B8F31F767Q50248460-421B3555-1504-43F4-8D42-522755708CA1Q54049239-E4DBE52D-ACAC-4682-9ECC-3E409136CF3CQ58128345-765DBCC2-FF99-44C0-9447-532F0F24ADD9Q60438255-E936C26D-D22C-4740-B435-1FC3E96EBCCAQ60438309-E63A406E-13C2-4250-9D76-986C55EEC5CDQ60438322-8F4ABFF8-6999-4186-9DC1-4FD76E760411
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Eulalia Martí
@ast
Eulalia Martí
@en
Eulalia Martí
@es
Eulalia Martí
@nl
Eulalia Martí
@sl
type
label
Eulalia Martí
@ast
Eulalia Martí
@en
Eulalia Martí
@es
Eulalia Martí
@nl
Eulalia Martí
@sl
prefLabel
Eulalia Martí
@ast
Eulalia Martí
@en
Eulalia Martí
@es
Eulalia Martí
@nl
Eulalia Martí
@sl
P1053
L-2775-2014
P106
P21
P31
P3829
P496
0000-0002-1030-3158